Key Milestones and Growth Path:

Founded with a focus on cell culture media and a commitment to “Made in Germany” quality, establishing a reputation for excellence and reliability.

Launch of Panserin, an innovative serum-free media series to boost cell culture performance.

Introduced Panexin, the world’s first serum-replacement product, revolutionizing cell culture by providing a reliable alternative to traditional serum. Panexin offered:

• • Consistency: Ensured uniform cell culture environments for reproducible results.
  • Reduced Variables: Eliminated variability from animal-derived serum, improving experimental accuracy.
  • Enhanced Growth: Supported optimal cell growth for research and production.

Achieved ISO 9001 and ISO 13485 certifications, highlighting PAN-Biotech’s commitment to high standards in quality management and regulatory compliance.

Expanded into international markets with distribution partnerships in over 70 countries, strengthening its global presence.

Developed the PANsys 3000 System, a fully automated cell culture system

Formed strategic alliances with leading industry partners to offer OEM (Original Equipment Manufacturer), CMO (Contract Manufacturing Organization), and CDMO (Contract Development and Manufacturing Organization) services, providing comprehensive support from development to commercialization.

Launched the eShop by PAN-Biotech, offering over 1,800 products online, with 85% in stock for rapid worldwide delivery within 2 days.

Started the Save the Planet initiative to reduce the industry’s carbon footprint with a waste recycling system that includes over 1,000 collection points and recycling of more than 300,000 cell culture media bottles, emphasizing sustainability and environmental responsibility.

Achieved FDA registration, expanding the company’s ability to serve clients in the United States.

Expanded the product portfolio with Biosolutions by PAN, introducing a range of new products including media, reagents, and buffers to enhance research and production capabilities.

Opened a new production facility operating at EU GMP Annex 1 standards to meet rigorous European standards for good manufacturing practice, ensuring the highest quality and safety of PAN-Biotech’s products.